Medicine only helps if you take it properly. And adhering to an exact schedule of what to take,...
Older adults who take aspirin and ibuprofen may face added heart risk. ...
There's heightened concern after the confirmation of more cases of the deadly Middle East Respiratory Syndrome, or MERS, in Saudi Arabia and Jordan over the weekend.
Report details the dangers of testing Ebola, which has already claimed the lives of 14 healthcare workers.
Tied to an unpopular president and his signature health care law, Democrats in the nation's largest swing state see medical marijuana as a potential antidote to political malaise in this year's midterm elections.
Women are at higher risk for some eye diseases than men and the majority aren't aware of this.
Report details the public health risks of skipping childhood vaccines.
Two new studies describe the latest achievements in growing body parts in a lab and transplanting them into people, this time with nostrils and vaginas. Windpipes, bladders, blood vessels and other structures have previously been created in part from a patient's own cells and then implanted.
FIFA's medical chief is "really not happy" with drug-testing plans for the World Cup in Brazil because samples taken from players must be flown across the Atlantic for analysis at a laboratory in Switzerland, which could slow results.
As GranuFlo lawsuits stemming from the 2012 recall of GranuFlo and NaturaLyte dialysis concentrates continue to move forward in the U.S., Bernstein Liebhard LLP notes that Fresenius Medical Care has announced a new NaturaLyte recall in Canada.
Rampant misinformation about Zohydro ER continues to be reported by the media and echoed in Washington D.C. and some states' capitals. These inaccurate and misleading statements are often made without proper context, and are intended to be sensational, to create fear or to generate headlines.
Maine's severe restrictions on opioid painkillers for Medicaid patients, requiring many to instead seek alternative pain management treatment for the past year, have sharply reduced the number of people obtaining highly addictive medications blamed for drug abuse and deaths around the nation.
Medicare paid a tiny group of doctors $3 million or more apiece in 2012. One got nearly $21 million. Those are among the findings of an Associated Press analysis of physician data released Wednesday by the Obama administration, part of a move to open the books on health care financing.
ERYTECH Pharma, a French biopharmaceutical company that develops treatments for acute leukemia and other oncology indications with unmet medical needs, announces the addition of a new product development candidate, ERY-MET, to the company’s tumor starvation product pipeline.
Though not yet available in the U.S., ultrasound ablation is part of the prostate cancer treatment spectrum in other countries. MRI-guided treatment is currently in clinical trials in the U.S. for low-risk prostate cancer, though it is yet to be approved by the Federal Drug Administration (FDA).
The nation's largest pharmacy benefits manager says that patients from the health care overhaul's new insurance exchanges have been more likely to use expensive specialty drugs for chronic conditions.
Dating to the days when the guillotine operator or the hangman wore a mask, a certain amount of anonymity has always surrounded executions. But that secrecy is increasingly coming under fire, with judges, death penalty opponents and lawyers questioning why so little can be known about a state's most solemn responsibility.
It's the Truvada conundrum: A drug hailed as a lifesaver for many people infected by HIV is at the heart of a rancorous debate among gay men, AIDS activists and health professionals over its potential for protecting uninfected men who engage in gay sex without using condoms.
The nation's disease detectives are beginning a program to try to outsmart outbreaks by routinely decoding the DNA of potentially deadly bacteria and viruses.
An experimental drug has shown encouraging results in treating advanced breast cancer in an early clinical trial, pharmaceutical giant Pfizer reported Sunday.
When an Ebola virus outbreak occurred in West Africa last month, officials for Broomfield-based Corgenix Medical Corp. scrambled and raided their local laboratory coolers to assemble a potential line of defense: prototype tests developed to detect the deadly virus in a matter of minutes.
A new study in the American Journal of Hypertension says that too little salt can be equally as dangerous as too much.
Three of eight people who contracted bacterial meningitis this year have died, and all three had sex with other men, Los Angeles County health officials said.
Attorneys for a serial killer asked the U.S. Supreme Court to halt his execution set for Thursday in Texas as they challenge that state's refusal to release information about where it gets its lethal injection drug.
Schuyler Ebersol turned to writing to help overcome a strange disease.
Nearly 20% of breast cancers diagnosed by mammogram would never cause problems if left alone, according to a new report.
Doctors say the main cause is more parents choosing not to have their children vaccinated.
- Page 1